LCID

Lucid Motors

$2.50

-10.39%
Nov 20, 2026
Bobby Quantitative Model
Lucid Group is a vertically integrated electric vehicle manufacturer that designs, engineers, and builds luxury and premium EVs, led by its flagship Lucid Air sedan and the upcoming Gravity SUV and Cosmos mid-size platform, selling direct-to-consumer through company-owned retail and service locations across North America, the Middle East, and other international markets. The company positions itself as a technology-first, clean-sheet engineering play in the premium EV space, distinguished by in-house hardware and software development and class-leading efficiency and range claims, but it remains a sub-scale manufacturer competing against Tesla, legacy luxury OEMs, and a wave of well-capitalized EV entrants. The current investor narrative is dominated by a make-or-break turnaround: repeated delays to the Cosmos SUV, an executive talent exodus, declining production and deliveries, and persistent multi-billion-dollar cash burn have raised the probability of another highly dilutive capital raise, while a cost-cutting "operating reset" and a 25,000-unit autonomous-vehicle commitment from Bolt are cited as potential catalysts that remain years from materializing. Management commentary dashing hopes for near-term EV-friendly legislation and a Q3 revenue and earnings miss have reinforced the bear case, leaving the stock trading as a high-risk, binary bet on liquidity and execution rather than a growth-at-a-reasonable-price story.

People also watch

Tesla

Tesla

TSLA

Analysis
General Motors

General Motors

GM

Analysis
Ford Motor Company

Ford Motor Company

F

Analysis
Rivian Automotive

Rivian Automotive

RIVN

Analysis
Harley-Davidson

Harley-Davidson

HOG

Analysis

BobbyInvestment Opinion: Should I buy LCID Today?

Rating: Sell / Avoid at current levels. The core thesis is that Lucid is a liquidity story masquerading as a growth story: with $989.0M of cash against -$6.64B trailing free cash flow and Q3 operating burn of -$752.6M plus $287.1M capex, the company has roughly one quarter of runway before another highly dilutive raise, and the consensus Hold rating (six analysts, lone Buy from Citigroup, Morgan Stanley Underweight, no upgrades in months) with an average EPS estimate of -$2.57 offers no valuation floor to anchor a buy case.

Supporting evidence is uniformly negative on fundamentals: Q3 2026 revenue of $350.3M grew just 4.08% YoY and fell sequentially from $405.3M in Q2, gross margin is -73.73% (roughly -$0.74 lost per dollar of revenue), net margin is -199.30%, operating margin -258.66%, and ROE -376.15%. The only coherent valuation metric, PS of 2.43x, is not cheap for a sub-scale manufacturer with negative gross margins and shrinking sequential revenue, while the 4.59x price-to-book sits atop a deeply negative equity return; the forward PE of 0.16x and EV/EBITDA of -1.47x are statistical artifacts, not value signals. The stock sits at $2.50, exactly its 52-week low and 0% of range, down 78.67% over one year with -83.34 points of relative underperformance versus the S&P 500, confirming company-specific capitulation rather than a beta-driven discount.

Three risks would invalidate even a speculative long: another equity raise at or below $2.50 (near-certain given runway), a further Cosmos SUV delay that pushes the volume ramp out again, and continued executive attrition that undermines execution credibility. The rating would upgrade to Hold only if Lucid secures non-dilutive or strategic funding plus two consecutive quarters of gross margin improvement toward -40% and sequential revenue growth; it would move toward Buy only on a credible path to positive gross margin with the Cosmos launch confirmed. On valuation, the stock is expensive relative to its fundamentals and only cheap relative to its own collapsed history (PS down from 61.4x in Q4 2023), which is a de-rating driven by deterioration, not an opportunity.

Sign up to view all

LCID 12-Month Price Forecast

The forward view is dominated by a single question: how Lucid funds itself before the Cosmos ramp can generate volume. With roughly one quarter of cash runway, a -73.73% gross margin, and revenue growth of just 4.08%, the base case (50% probability) is a dilutive raise that stabilizes the balance sheet but caps the stock in the $2.00-$2.80 range, while the bear case (35%) of a discounted raise or another delay takes it to $1.50-$2.00. The bull case (15%) requires non-dilutive funding plus tangible margin progress to reclaim the $3.60-$3.77 resistance and approach RBC's $4 target. Analyst sentiment reinforces caution: six analysts, a lone Buy, Morgan Stanley Underweight, and no upgrades in months, with an EPS estimate spread of -$1.96 to -$3.59 signaling low conviction. I would upgrade to neutral on a confirmed non-dilutive funding event plus two quarters of gross margin improvement, and downgrade further only if a raise is priced below $2.00 or going-concern language appears.

Historical Price
Current Price $2.50
Average Target $2.50
High Target $2.88
Low Target $2.13

Wall Street consensus

Six analysts cover Lucid, and the consensus is decidedly cautious: the distribution skews neutral-to-bearish, with Citigroup the lone Buy, Baird, TD Cowen, and Cantor Fitzgerald at Neutral/Hold, RBC at Sector Perform, and Morgan Stanley at Underweight. The consensus recommendation is effectively Hold with a bearish tilt, and the estimated average EPS of -$2.57 (range of -$3.59 to -$1.96) confirms analysts expect continued heavy losses. Specific price targets are not provided in the dataset, so implied upside cannot be calculated; however, the recent RBC $4 price target cited in October coverage versus the current $2.50 price implies roughly 60% upside to that single target, though it was set before the latest leg down and likely understates the current gap.

The target range and ratings pattern reveal high uncertainty and negative momentum: the EPS estimate spread from -$1.96 to -$3.59 is wide, signaling low conviction on the pace of loss narrowing, and the institutional ratings show no upgrades in the past several months — Citigroup has reiterated Buy since May, but Morgan Stanley has held Underweight since October and RBC has stayed at Sector Perform, with no firm moving more constructive despite the stock's collapse. The high end of estimates would require a successful Cosmos launch, cost reset, and possibly external partnership revenue (such as the Bolt AV commitment) to materialize, while the low end prices in continued delays, margin compression, and another dilutive raise. With only six analysts and a wide dispersion, coverage is thin for a company of this profile, which typically amplifies volatility and reduces price-discovery efficiency — investors should treat the consensus as a weak signal and weight the liquidity and dilution risk more heavily than any single target.

Drowning in data?

Find the real signal!

Bulls vs Bears: LCID Investment Factors

The bear case currently holds stronger evidence: a one-quarter cash runway against -$6.64B trailing free cash flow, a -73.73% gross margin, decelerating 4.08% revenue growth, and a stock at its 52-week low with -83.34 points of one-year relative underperformance. The bull case rests on sequential margin improvement, a lone Citigroup Buy with roughly 60% implied upside to RBC's $4 target, the Bolt AV optionality, and a PS multiple compressed to 2.43x from 61.4x in Q4 2023. The single most important tension is liquidity versus dilution: if Lucid secures non-dilutive funding or a strategic partner before cash runs out, the compressed multiple could re-rate sharply, but a conventional equity raise at $2.50 would transfer most of the remaining equity value away from current holders. Until the Cosmos launch and cost reset produce tangible delivery and margin evidence, the risk/reward is skewed to the downside despite the depressed price.

Bullish

  • Gross margin improving sequentially: Gross margin improved from -105.27% in Q2 2026 to -73.73% in Q3 2026, a 31.5 percentage-point sequential gain that suggests the cost-cutting 'operating reset' is beginning to bite. Cost of revenue fell from $832.1M in Q2 to $608.6M in Q3 even as revenue declined, indicating some variable-cost discipline.
  • Lone Buy rating with 60% implied upside: Citigroup has held a Buy rating since May, and RBC's October $4 price target implies roughly 60% upside from the current $2.50. Even after the latest leg down, the single published target sits well above the current price, suggesting some sell-side models still assign value to the Cosmos and cost-reset story.
  • Bolt AV commitment adds optionality: The 25,000-unit autonomous-vehicle commitment from Bolt is a potential external revenue stream that does not depend on consumer EV demand. It is years from materializing, but it represents a differentiated demand channel that most sub-scale EV peers lack.
  • PS multiple near historical trough: The price-to-sales ratio has compressed from 61.4x in Q4 2023 and 36.6x in Q4 2024 to 2.43x today, near the bottom of its own historical band. If the business merely stabilizes, the de-rating has already priced in a great deal of bad news.

Bearish

  • Cash runway of roughly one quarter: Lucid ended Q3 2026 with only $989.0M in cash against trailing free cash flow of -$6.64B and Q3 operating cash burn of -$752.6M plus $287.1M of capex. At that pace, another highly dilutive capital raise appears near-certain, and the company already raised $1.20B in net financing in Q3 alone.
  • Catastrophic negative gross margins: Q3 2026 gross margin of -73.73% means Lucid loses about $0.74 at the gross line for every dollar of revenue, with gross profit of -$258.3M. Trailing net margin of -199.30% and operating margin of -258.66% are far outside even early-stage EV norms, and the company is nowhere near the positive gross margin that would validate its manufacturing model.
  • Revenue decelerating and sub-scale: Q3 2026 revenue of $350.3M grew just 4.08% year-over-year and fell sequentially from $405.3M in Q2, well below the $522.7M Q4 2025 peak. With the Cosmos SUV delayed again and $25.4M of the top line coming from low-quality regulatory credits, the volume ramp needed to absorb the cost base keeps slipping.
  • Falling knife at 52-week low: At $2.50 the stock sits at 0% of its 52-week range, down 78.67% over one year and 54.63% over three months, with a 10.39% single-day drop on 15.55M shares. Relative strength versus the S&P 500 is -83.34 points over one year, confirming company-specific capitulation rather than beta-driven weakness.

LCID Technical Analysis

Lucid is locked in a severe, sustained downtrend, with the shares down 78.67% over the trailing year and 77.58% year-to-date, a collapse that has erased roughly 87.43% from peak to trough (max drawdown). At $2.50, the stock sits essentially at the very bottom of its 52-week range, having printed a low of $2.50 on the most recent session versus a range high near $8.12 set in late July 2026 — meaning the current price is at approximately 0% of the 52-week range, the definition of a falling knife rather than a value opportunity. This positioning signals capitulation-style selling pressure and an absence of buyers willing to defend support, with no technical evidence yet of a base forming.

Short-term momentum is accelerating to the downside rather than stabilizing: the stock is down 22.12% over the past month and 54.63% over three months, with the one-month decline steeper than the three-month pace, indicating deterioration is intensifying. The most recent session alone saw a 10.39% drop on elevated volume of roughly 15.55 million shares, a high-volume breakdown that typically reflects forced selling or fresh negative catalysts rather than orderly profit-taking. Relative strength confirms the divergence from the broader market: Lucid has underperformed the S&P 500 by 12.41 percentage points over one month and a staggering 83.34 points over one year, while the benchmark itself fell 9.71% in the past month — Lucid's decline is company-specific, not merely beta-driven.

Key technical levels are stark: immediate support is the $2.50 low, and a decisive break below it would open the door to sub-$2 territory with no historical reference points to catch the fall, while any meaningful resistance now sits far overhead at the $3.60–$3.77 area where the stock failed in early November, and the July high of $8.12 is a distant ceiling. A reclaim of $3.60 would be the first sign of a short-term bottom, but a breakout above the 52-week high is not a realistic near-term scenario. Volatility is extreme — a 10.39% single-day move and a 54.63% three-month decline imply realized volatility far in excess of the market, and with a beta that is effectively amplified by idiosyncratic liquidity risk, position sizing must assume the possibility of another 30–50% drawdown from current levels.

Beta

—

—

Max Drawdown

-87.4%

Largest decline past year

52-Week Range

—

Price range past year

Annual Return

-78.7%

Cumulative gain past year

PeriodLCID ReturnS&P 500
1m-22.1%-9.2%
3m-54.6%-9.7%
6m-57.2%-8.1%
1y-78.7%+4.7%
ytd-77.6%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

LCID Fundamental Analysis

Revenue is growing but at a decelerating and deeply sub-scale pace: Q3 2026 revenue of $350.3 million rose just 4.08% year-over-year, a sharp slowdown from the $405.3 million booked in Q2 2026 and only modestly above the $336.6 million in the year-ago quarter. The multi-quarter trajectory is troubling — revenue fell sequentially from $405.3 million in Q2 to $350.3 million in Q3, and the prior Q4 2025 peak of $522.7 million has not been approached since, consistent with declining production and deliveries cited in recent coverage. Regulatory credits contributed $25.4 million of the top line, a low-quality, volatile revenue source, and with the Cosmos SUV delayed again, the volume ramp needed to justify the cost base keeps slipping to the right.

Profitability is deeply negative and worsening in absolute terms: Q3 2026 net income was -$830.9 million on a gross margin of -73.73%, meaning Lucid loses roughly $0.74 for every dollar of revenue at the gross line, and gross profit was -$258.3 million. The Q2 2026 quarter was even worse, with a -105.27% gross margin and a -$1.26 billion net loss, while the trailing net margin stands at -199.30% and operating margin at -258.66% — figures that are catastrophic even by early-stage EV standards, where negative gross margins during ramp are common but rarely this severe. The one silver lining is sequential improvement in gross margin from -105.27% in Q2 to -73.73% in Q3, suggesting the cost-cutting reset is having some effect, but the company remains far from the positive gross margins that would signal a viable manufacturing model.

Financial health is the central risk: trailing twelve-month free cash flow is -$6.64 billion, with Q3 operating cash flow of -$752.6 million and capital expenditures of -$287.1 million, and the company ended Q3 with only $989.0 million in cash — roughly one quarter of burn at current rates. Debt-to-equity stands at 1.20x, the current ratio is a thin 1.25, and ROE is -376.15%, reflecting both massive losses and a shrinking equity base; the company has been funding itself through financing, raising $1.20 billion in net financing cash in Q3 alone and issuing stock repeatedly. With cash coverage of roughly one quarter and no clear path to breakeven, another dilutive raise appears near-certain, and the negative $1.11 price-to-cash-flow ratio underscores that operations consume rather than generate cash.

Quarterly Revenue

$350319000.0B

2026-09

Revenue YoY Growth

+4.1%

YoY Comparison

Gross Margin

-73.7%

Latest Quarter

Free Cash Flow

$-6.6B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Regulatory Credits

Open an Account, get $2 TSLA now!

Valuation Analysis: Is LCID Overvalued?

Because Lucid's net income is deeply negative (trailing EPS of -$0.82 and a trailing PE of -0.90x), the PE ratio is not meaningful, and I therefore lead with the price-to-sales ratio of 2.43x as the primary metric, supplemented by the price-to-book ratio of 4.59x. The forward PE of 0.16x is a statistical artifact of a near-zero or negative forward earnings estimate rather than a genuine valuation signal, and the negative EV/EBITDA of -1.47x confirms the company has no positive earnings base to value. The PS multiple of 2.43x is the only ratio that offers a coherent read: the market is paying about $2.43 for every dollar of trailing revenue, which for a company with negative gross margins and shrinking sequential revenue is a rich price.

Peer comparison is constrained by the absence of a formal industry-average dataset in the provided valuation inputs, but context is instructive: Lucid's 2.43x PS sits well below its own historical peaks but above what a sub-scale, cash-burning manufacturer with a -73.73% gross margin would typically command relative to profitable automakers trading in the low-to-mid single digits on earnings. The 4.59x price-to-book is elevated for a company with a -376.15% ROE, implying the market is valuing intangible technology and brand optionality rather than book value. On any profitability-adjusted basis, Lucid screens as expensive relative to its fundamentals, and the premium can only be justified by a successful Cosmos ramp and cost reset that have both been repeatedly delayed.

Historically, Lucid's PS ratio has compressed dramatically from 61.4x in Q4 2023 and 36.6x in Q4 2024 to 4.58x in Q3 2026, a decline that reflects both the collapse in share price and the growth in revenue — the multiple is now near the bottom of its own historical band. That compression cuts both ways: it could signal a value opportunity if the business stabilizes, but the simultaneous deterioration in gross margin, cash position, and delivery trends suggests the de-rating is fundamentally driven rather than sentiment-driven. The price-to-book ratio has also fallen from 15.9x in Q4 2021 to 4.59x today, consistent with a stock that has been repriced for a much less optimistic outcome.

PE

-0.9x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

21.9x

Industry PE ~21.9x*

EV/EBITDA

-1.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are existential rather than incremental. Lucid held just $989.0M of cash at Q3 2026 against -$6.64B of trailing free cash flow, with Q3 operating cash flow of -$752.6M and capex of -$287.1M, implying roughly one quarter of runway before another raise. Gross margin of -73.73% and a -$830.9M quarterly net loss mean the company burns cash on every vehicle sold, while debt-to-equity of 1.20x and a thin 1.25 current ratio leave little balance-sheet cushion. Revenue concentration in the aging Air sedan, a 4.08% YoY growth rate, and $25.4M of regulatory-credit revenue add earnings volatility on top of the liquidity problem.

Market and competitive risks compound the financial strain. At 2.43x sales and 4.59x book with a -376.15% ROE, Lucid trades at a premium to profitable automakers on any profitability-adjusted basis, leaving room for further multiple compression if the Cosmos ramp slips again. The stock's -83.34 point one-year relative strength versus the S&P 500 and -12.41 point one-month gap show the decline is idiosyncratic, not macro-driven, and the executive exodus plus repeated delays erode the execution credibility needed to defend a premium. Competition from Tesla, Rivian's better-funded R2 ramp (backed by a $4.5B DOE loan), and legacy luxury OEMs intensifies pricing pressure in the premium EV segment just as Lucid needs volume.

The worst-case scenario is a dilutive equity raise at or below $2.50 combined with a further Cosmos delay, which would crush per-share value and could push the stock into sub-$2 territory with no historical support. The 52-week low is $2.50 — the current price — and the max drawdown is -87.43%, so a break below support could realistically take the stock another 20-40% lower toward $1.50-$2.00, a loss of roughly -20% to -40% from current levels. A failed capital raise or going-concern language would be the trigger for that tail outcome.

FAQ

The most severe risk is financial and existential: $989.0M of cash against -$6.64B trailing free cash flow and -$752.6M of Q3 operating burn implies roughly one quarter of runway, making another highly dilutive raise near-certain after $1.20B of net financing was already raised in Q3 alone. Second is the operating risk embedded in a -73.73% gross margin and -199.30% net margin, meaning Lucid loses about $0.74 at the gross line per dollar of revenue and remains far from the positive gross margin that would validate its manufacturing model. Third is competitive and execution risk: the Cosmos SUV has been delayed again, the Air sedan carries the volume, $25.4M of revenue came from low-quality regulatory credits, and an executive talent exodus undermines credibility while Rivian's better-funded R2 ramp (backed by a $4.5B DOE loan) and Tesla intensify premium EV pricing pressure. Fourth is market and momentum risk: at 0% of its 52-week range with a -87.43% max drawdown, a 10.39% single-day drop on 15.55M shares, and -83.34 points of one-year relative weakness versus the S&P 500, forced selling and thin six-analyst coverage can amplify further declines.

The 12-month forecast is split into three scenarios: a 50% base case of $2.00-$2.80 in which a dilutive raise near $2.50 stabilizes the balance sheet but caps per-share upside while revenue holds near $350M quarterly and gross margin grinds toward -50% to -70%; a 35% bear case of $1.50-$2.00 driven by a discounted raise, another Cosmos delay, or going-concern language breaking the $2.50 support with no historical reference below it; and a 15% bull case of $3.60-$4.00 requiring non-dilutive strategic funding, a firm Cosmos launch date, and a second consecutive 20+ point gross margin improvement. The base case is most likely, and its key assumption is that Lucid funds itself conventionally within one to two quarters without a collapse in the share price, keeping the stock range-bound in the low-to-high $2s. The probabilities sum to 100 and the skew is clearly negative: the bear case's -20% to -40% downside is larger and more probable than the bull case's upside, consistent with the bearish AI stance and high confidence.

With trailing EPS of -$0.82 and a trailing PE of -0.90x, earnings-based multiples are meaningless, so the price-to-sales ratio of 2.43x is the only coherent anchor — and it is not cheap for a sub-scale manufacturer with a -73.73% gross margin and revenue that fell sequentially from $405.3M to $350.3M. The 4.59x price-to-book sits atop a -376.15% ROE, meaning the market is paying for intangible technology and brand optionality rather than book value, while the 0.16x forward PE and -1.47x EV/EBITDA are statistical artifacts of negative estimates, not value signals. Relative to its own history the multiple has collapsed from 61.4x sales in Q4 2023 and 36.6x in Q4 2024, so on that narrow comparison it looks cheap — but the de-rating coincided with deteriorating margins, cash, and deliveries, which suggests it is fundamentally driven rather than a sentiment-driven discount. The market is effectively pricing a high probability of further dilution and a low probability of a successful Cosmos ramp, so the stock is expensive relative to fundamentals and only superficially cheap relative to its own collapsed past.

From a risk/reward standpoint, LCID is not a good buy for most investors at $2.50: the downside case (35% probability) targets $1.50-$2.00, a further -20% to -40%, while the base case (50%) caps upside around $2.00-$2.80 as a dilutive raise absorbs equity value, leaving only the 15% bull case pointing to $3.60-$4.00. The reward side is real but thin — RBC's $4 target implies roughly 60% upside and Citigroup is the lone Buy — yet that target predates the latest leg down and the consensus remains Hold with a bearish tilt and no upgrades in months. The biggest downside risk is a raise priced at or below $2.50, which would transfer most remaining equity value away from current holders given roughly one quarter of cash runway against -$752.6M of quarterly operating burn. It could be a reasonable speculative buy only for investors who can tolerate a total or near-total loss, size the position accordingly, and are waiting specifically for a confirmed non-dilutive funding event plus two quarters of gross margin improvement before committing capital.

LCID is not suitable for long-term buy-and-hold capital in its current form: with roughly one quarter of cash runway, a 0% dividend yield, deeply negative earnings visibility (consensus EPS of -$2.57, range -$3.59 to -$1.96), and a -87.43% max drawdown, the equity carries a real risk of permanent dilution before the Cosmos ramp can generate volume. Its extreme volatility — a 10.39% single-day move, a -54.63% three-month decline, and -83.34 points of one-year relative underperformance — makes it a trading vehicle for momentum and event-driven traders rather than a compounding holding, and the stock's position at 0% of its 52-week range means short-term traders are fighting a confirmed downtrend. Any position should be treated as speculative capital with a minimum 12-24 month horizon only for investors willing to underwrite the full funding and Cosmos launch cycle, and even then only after a confirmed non-dilutive funding event and two quarters of gross margin improvement. A practical rule is to avoid initiating a position before the next capital raise is priced, since that event will determine whether current holders retain meaningful equity value.